Muscarinic receptor blockade by pirenzepine: effect on prolactin secretion in man
- PMID: 6808052
- DOI: 10.1007/BF03350483
Muscarinic receptor blockade by pirenzepine: effect on prolactin secretion in man
Abstract
The effect of pirenzepine, a muscarinic receptor blocker which does not cross the blood brain barrier, on basal and TRH-stimulated prolactin (PRL) secretion in normal subjects was studied. Administration of 75 mg oral pirenzepine had no effects on prolactin levels in male subjects whereas it significantly reduced prolactin in females. No effect on TRH induced prolactin secretion was observed.
Similar articles
-
Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man.J Clin Endocrinol Metab. 1982 Dec;55(6):1231-3. doi: 10.1210/jcem-55-6-1231. J Clin Endocrinol Metab. 1982. PMID: 6897069
-
Inhibition via muscarinic M-1 receptor stimulation of TRH-induced prolactin release in estrogen-primed rats.Arch Int Pharmacodyn Ther. 1988 May-Jun;293:236-44. Arch Int Pharmacodyn Ther. 1988. PMID: 2901825
-
Lack of effect of muscarinic cholinergic blockade on the GH responses to GRF 1-29 and TRH in acromegalic subjects.Clin Endocrinol (Oxf). 1986 Apr;24(4):415-20. doi: 10.1111/j.1365-2265.1986.tb01646.x. Clin Endocrinol (Oxf). 1986. PMID: 2874906 Clinical Trial.
-
Muscarinic regulation of basal versus thyrotropin-releasing hormone-induced prolactin secretion in rat anterior pituitary cells. differential roles of nitric oxide and intracellular calcium mobilization.Neuroendocrinology. 1999 Nov;70(5):324-31. doi: 10.1159/000054493. Neuroendocrinology. 1999. PMID: 10567858
-
[MI cholinergic receptors of gastric secretion: current status].J Pharmacol. 1985;16 Suppl 2:145-69. J Pharmacol. 1985. PMID: 2867250 Review. French.
Cited by
-
Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.Drugs. 1985 Aug;30(2):85-126. doi: 10.2165/00003495-198530020-00001. Drugs. 1985. PMID: 3928324 Review.
-
Drug-induced changes in prolactin secretion. Clinical implications.Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):463-98. doi: 10.1007/BF03259897. Med Toxicol Adverse Drug Exp. 1988. PMID: 3063922 Review.
-
Drugs in Lactation.Pharm Res. 2018 Feb 6;35(3):45. doi: 10.1007/s11095-017-2287-z. Pharm Res. 2018. PMID: 29411152 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources